Novo Nordisk Launches the Sale of Wegovy at a Discounted Price of $499 per Month for Cash-Paying Patients
Reading Time: 3 minutes
The discounted medications will be provided to uninsured patients or patients whose insurance does not cover obesity medications through a program called NovoCare Pharmacy. Pharmaceutical company Novo Nordisk (i) is taking on Hims & Hers (i) and is now trying to win back patients it has lost to competitors that have been selling legal generic versions of its weight loss drug Wegovy for some time. Novo Nordisk announced on March 5, 2025, that it will sell Wegovy through its own online pharmacy at lower prices to uninsured patients and those...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
